SE452065B - Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning - Google Patents

Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Info

Publication number
SE452065B
SE452065B SE8601644A SE8601644A SE452065B SE 452065 B SE452065 B SE 452065B SE 8601644 A SE8601644 A SE 8601644A SE 8601644 A SE8601644 A SE 8601644A SE 452065 B SE452065 B SE 452065B
Authority
SE
Sweden
Prior art keywords
antibodies
fragments
region
antibody preparation
bound
Prior art date
Application number
SE8601644A
Other languages
English (en)
Swedish (sv)
Other versions
SE8601644D0 (sv
SE8601644L (sv
Inventor
Ulf R Nilsson
Karl-Erik Svensson
Bo Nilsson
Original Assignee
Ulf R Nilsson
Svensson Karl Erik
Bo Nilsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulf R Nilsson, Svensson Karl Erik, Bo Nilsson filed Critical Ulf R Nilsson
Priority to SE8601644A priority Critical patent/SE452065B/sv
Publication of SE8601644D0 publication Critical patent/SE8601644D0/xx
Priority to PCT/SE1987/000142 priority patent/WO1987006344A1/en
Priority to EP19870902799 priority patent/EP0263161A1/en
Priority to JP50252087A priority patent/JPS63503089A/ja
Priority to AU72868/87A priority patent/AU7286887A/en
Publication of SE8601644L publication Critical patent/SE8601644L/
Publication of SE452065B publication Critical patent/SE452065B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8601644A 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning SE452065B (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
PCT/SE1987/000142 WO1987006344A1 (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
EP19870902799 EP0263161A1 (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof
JP50252087A JPS63503089A (ja) 1986-04-11 1987-03-19 ヒトｃ３中のある抗原決定基に対する抗体調製物及びその使用並びにその生産
AU72868/87A AU7286887A (en) 1986-04-11 1987-03-19 Antibody preparation directed against neoantigens in human c3 (complement factor 3) and the use and manufacture thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Publications (3)

Publication Number Publication Date
SE8601644D0 SE8601644D0 (sv) 1986-04-11
SE8601644L SE8601644L (sv) 1987-10-12
SE452065B true SE452065B (sv) 1987-11-09

Family

ID=20364149

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8601644A SE452065B (sv) 1986-04-11 1986-04-11 Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning

Country Status (5)

Country Link
EP (1) EP0263161A1 (ja)
JP (1) JPS63503089A (ja)
AU (1) AU7286887A (ja)
SE (1) SE452065B (ja)
WO (1) WO1987006344A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572856B1 (en) 1998-09-10 2003-06-03 The University Of Virginia Patent Foundation Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies
CA2328356A1 (en) * 1999-12-22 2001-06-22 Itty Atcravi Recreational vehicles
JP2003522159A (ja) * 2000-02-08 2003-07-22 ザ ユニバーシティ オブ ヴァージニア パテント ファウンデーション 抗Ｃ３ｂ（ｉ）抗体を用いる感染の予防および治療のための方法
US6617308B2 (en) 2001-04-30 2003-09-09 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons
US6998243B2 (en) * 2001-04-30 2006-02-14 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
US7294688B2 (en) 2001-04-30 2007-11-13 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
US6602855B2 (en) * 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
US20020160434A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1777 daltons
US7314717B2 (en) 2001-04-30 2008-01-01 Nanogen Inc. Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
US20040224423A1 (en) * 2001-04-30 2004-11-11 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons
US20020160532A1 (en) * 2001-04-30 2002-10-31 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons
US7049397B2 (en) * 2001-04-30 2006-05-23 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons
US6593298B2 (en) * 2001-04-30 2003-07-15 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons
US6756476B2 (en) * 2001-04-30 2004-06-29 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
AR069130A1 (es) * 2007-11-02 2009-12-30 Novartis Ag Moleculas de enlace de la opsonina principal del complemento (c3b) y metodos para modular el componente de complemento
US20100291106A1 (en) * 2009-05-06 2010-11-18 Novartis Ag Compositions and methods for antibodies targeting complement protein c3b
EP2553465A4 (en) * 2010-03-31 2013-10-23 Anamar Ab METHOD FOR DETECTING INFLAMMATION TISSUE DEGRADATION
ES2564290T3 (es) 2010-11-02 2016-03-21 Kypha, Inc. Inmunoensayo de flujo lateral para la activación de complemento y métodos de uso para evaluación del sitio de atención de trastornos asociados a complemento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
GB2117514B (en) * 1982-03-29 1985-08-29 East Anglian Regional Health Polyvalent antiglobulin reagent
US4642284A (en) * 1983-06-13 1987-02-10 Scripps Clinic And Research Foundation Method and system for detection of complement pathway activation

Also Published As

Publication number Publication date
WO1987006344A1 (en) 1987-10-22
EP0263161A1 (en) 1988-04-13
JPS63503089A (ja) 1988-11-10
AU7286887A (en) 1987-11-09
SE8601644D0 (sv) 1986-04-11
SE8601644L (sv) 1987-10-12

Similar Documents

Publication Publication Date Title
SE452065B (sv) Antikroppspreparation vars antikroppar er specifika for determinanter i c3 b regionen hos denaturerat humant c3 samt dess anvendning och framstellning
Curtiss et al. A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.
AU2016203292B2 (en) Monoclonal antibody, and immunoassay using same
JP3673522B2 (ja) 抗アネキシンｖモノクローナル抗体並びにその利用及びそれを産生するハイブリドーマ細胞系
US9347954B2 (en) Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
Natvig Human anti-γ-globulin antibodies specific for γG heavy chain subclasses
JP2665503B2 (ja) インシュリン様成長因子の免疫分析を可能にするインシュリン様成長因子に対するモノクローナル抗体対
JPH1090268A (ja) 免疫学的粒子凝集反応方法
EP3184634B1 (en) PROTEIN ASSAY METHOD SPECIFIC TO TRACP-5b (TARTRATE RESISTANT ACID PHOSPHATASE 5b)
JPH026755A (ja) リポ蛋白粒子の免疫学的測定方法，抗Ｌｐ（ａ）モノクロナル抗体，およびそれらのアテローム性動脈硬化症の診断における使用
WO1990009587A1 (fr) Analyse immunologique de l'osteocalcine humaine, reactif et kit utilises pour ladite analyse, anticorps anti-osteocalcine humaine, hybridome produisant ledit anticorps, et procede de production de cet anticorps
EP0918218A2 (en) Method for immunological assay
JPH0843389A (ja) 血清アミロイドａの免疫学的測定法
EP0241443B1 (en) Reagent for and procedure in the determination of c3a by immunochemical assay
JP2001000181A (ja) 抗ヒトｃ反応性タンパク質モノクローナル抗体産生細胞ライン、およびその作製方法、ならびにモノクローナル抗体
JP2017214348A (ja) 糖ペプチドと反応するモノクローナル抗体およびその用途
JP2002209579A (ja) 抗ヒトヘモグロビンモノクローナル抗体、およびそれを産生する細胞株またはそれを含むヒトヘモグロビン検出用キット
JP2004215649A (ja) 抗ｃ反応性タンパク質モノクローナル抗体、これを産生する細胞株、抗ｃ反応性タンパク質モノクローナル抗体の作製方法、およびｃ反応性タンパク質検出キット
JP2021073435A (ja) 試料に含まれるペリオスチン測定の感度の改善方法
JP5585587B2 (ja) ５．９ｋＤａペプチドの免疫学的測定方法
JPH067189A (ja) ヒトＭ−ＣＳＦ β型ダイマ−に特異性を有するモノクロ− ナル抗体と、この抗体を産生するハイブリドーマ、お よびこの抗体の利用

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8601644-1

Effective date: 19911108

Format of ref document f/p: F